Chapter 32: Women's Healthcare

Loading audio…

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

If there is an issue with this chapter, please let us know → Contact Us

Cervical cytology screening and breast imaging represent critical preventive interventions, with the chapter distinguishing between benign breast pathologies such as fibrocystic changes and fibroadenomas versus malignant disease. Breast cancer receives extensive coverage, including genetic predisposition factors, classification systems for staging, and multimodal treatment approaches encompassing surgical options ranging from tissue-conserving procedures to radical resection, combined with adjuvant radiation, pharmaceutical chemotherapy, and endocrine therapy. The chapter addresses cardiovascular disease as the predominant cause of mortality in women, highlighting how atypical symptom presentations in women differ significantly from classic male presentations, alongside evidence-based prevention strategies. Reproductive endocrinology content examines menstrual cycle dysfunction including primary and secondary absence of menses, excessive bleeding patterns, and cyclic pain disorders including endometriosis, where ectopic endometrial proliferation causes significant morbidity. Management of premenstrual conditions ranging from mild syndrome to severe dysphoric manifestations receives detailed attention. Pregnancy termination methods are compared, including pharmacological approaches and surgical evacuation techniques. The climacteric and menopausal transition are explored with examination of vasomotor symptoms, tissue atrophy, and therapeutic options including hormone supplementation and bone density preservation. Pelvic floor anatomy and dysfunction are discussed with conservative and surgical interventions. The chapter concludes with benign and malignant neoplastic disorders of reproductive organs and comprehensive coverage of infectious pathology including bacterial, viral, and parasitic sexually transmitted infections, inflammatory conditions affecting the pelvis, and systemic infectious complications relevant to women's health.